207 related articles for article (PubMed ID: 15298716)
1. The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.
Martinez N; Drescher B; Riehle H; Cullmann C; Vornlocher HP; Ganser A; Heil G; Nordheim A; Krauter J; Heidenreich O
BMC Cancer; 2004 Aug; 4():44. PubMed ID: 15298716
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
[TBL] [Abstract][Full Text] [Related]
3. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.
Heidenreich O; Krauter J; Riehle H; Hadwiger P; John M; Heil G; Vornlocher HP; Nordheim A
Blood; 2003 Apr; 101(8):3157-63. PubMed ID: 12480707
[TBL] [Abstract][Full Text] [Related]
4. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia.
Issa H; Swart LE; Rasouli M; Ashtiani M; Nakjang S; Jyotsana N; Schuschel K; Heuser M; Blair H; Heidenreich O
Leukemia; 2023 Apr; 37(4):820-834. PubMed ID: 36823395
[TBL] [Abstract][Full Text] [Related]
6. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
[TBL] [Abstract][Full Text] [Related]
7. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
[TBL] [Abstract][Full Text] [Related]
8. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
9. RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner.
Abdallah MG; Niibori-Nambu A; Morii M; Yokomizo T; Yokomizo T; Ideue T; Kubota S; Teoh VSI; Mok MMH; Wang CQ; Omar AA; Tokunaga K; Iwanaga E; Matsuoka M; Asou N; Nakagata N; Araki K; AboElenin M; Madboly SH; Sashida G; Osato M
Leukemia; 2021 Oct; 35(10):2983-2988. PubMed ID: 34148054
[No Abstract] [Full Text] [Related]
10. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
Lam K; Zhang DE
Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
[TBL] [Abstract][Full Text] [Related]
11. Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.
Steffen B; Serve H; Berdel WE; Agrawal S; Linggi B; Büchner T; Hiebert SW; Müller-Tidow C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8448-53. PubMed ID: 12819347
[TBL] [Abstract][Full Text] [Related]
12. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
[TBL] [Abstract][Full Text] [Related]
14. Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system.
Theriault FM; Nuthall HN; Dong Z; Lo R; Barnabe-Heider F; Miller FD; Stifani S
J Neurosci; 2005 Feb; 25(8):2050-61. PubMed ID: 15728845
[TBL] [Abstract][Full Text] [Related]
15. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
[TBL] [Abstract][Full Text] [Related]
16. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
[TBL] [Abstract][Full Text] [Related]
17. Developmental-stage-dependent transcriptional response to leukaemic oncogene expression.
Regha K; Assi SA; Tsoulaki O; Gilmour J; Lacaud G; Bonifer C
Nat Commun; 2015 May; 6():7203. PubMed ID: 26018585
[TBL] [Abstract][Full Text] [Related]
18. Disruption of MAPK1 expression in the ERK signalling pathway and the RUNX1‑RUNX1T1 fusion gene attenuate the differentiation and proliferation and induces the growth arrest in t(8;21) leukaemia cells.
Bashanfer SAA; Saleem M; Heidenreich O; Moses EJ; Yusoff NM
Oncol Rep; 2019 Mar; 41(3):2027-2040. PubMed ID: 30569130
[TBL] [Abstract][Full Text] [Related]
19. A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia.
Walker LC; Stevens J; Campbell H; Corbett R; Spearing R; Heaton D; Macdonald DH; Morris CM; Ganly P
Br J Haematol; 2002 Jun; 117(4):878-81. PubMed ID: 12060124
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
Wolyniec K; Wotton S; Kilbey A; Jenkins A; Terry A; Peters G; Stocking C; Cameron E; Neil JC
Oncogene; 2009 Jul; 28(27):2502-12. PubMed ID: 19448675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
